<< Back
Price to Revenue (TTM)
This is the current Price divided by the Sales Per Share for the trailing twelve months. If there is a preliminary earnings announcement for an interim period that has recently ended, the revenue (sales) values from this announcement will be used in calculating the trailing twelve month revenue per share.
NASDAQ (US Dollar)
$67.49
 Stock is Down 0.34 (0.50%)
Data as of 03/23/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at RBC Capital Markets 2017 Global Healthcare Conference

February 22, 2017 9:30 a.m. ET
Play
Fourth Quarter 2016 Gilead Sciences Earnings Conference Call

February 07, 2017 4:30 p.m. ET
Play